|
2-Ethyl-4-[2′-(1H-tetrazol-5-yl)biphenyl-4-ylmethoxy]quinoline hydrochloride |
135015-84-8 (monoHCl) |
C25H21N5O.ClH |
|
(-)-(1R,2R)-N-Methyl-2-(3-pyridinyl)tetrahydro-2H-thiopyran-2-carbothioamide 1-oxide |
089544-10-5 (non-specific stereoch.); 092569-65-8 |
C12H16N2OS2 |
|
3′,3′-N-Bis(cyclopropylmethyl)-3′,3′-N-bis(desmethyl)-11-[2-(3-chloro-4-fluorophenyl)ethylamino]-11-deoxy-6-O-methylerythromycin A 11-N,12-O-(cyclic carbamate) |
|
C53H82ClFN2O13 |
|
6-Ethyl-6-phenylpyrido[3,2-b]pyrrolo[1,2-d][1,4]oxazepin-7(6H)-one |
|
C19H16N2O2 |
|
(6R,8aS)-6-Hydroxy-3-methoxy-11-(8-phthalimidooctyl)-5,6,9,10-tetrahydro-4aH-benzofuro[3a,3,2-ef][2]benzazepinium bromide |
|
C32H37N2O5.Br |
|
(±)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide monohydrochloride; (±)-6-Chloro-4-methyl-3-oxo-N-(3-quinuclidinyl)-3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide monohydrochloride |
141922-90-9; 123040-96-0 ((-)-enantiomer); 123040- |
C17H20ClN3O3.ClH |
|
(2S,7S)-N2,N2′-[2,7-Bis(pyroglutamyl-glutamyl-aspartylamino)octanedioyl]bis(lysine) |
134143-28-5 |
C48H74N12O22 |
|
(1S,3S,5R,9R,10R,11R,13R,14S,15R,17S,18R,19R,23Z,25R,27S,29S,31S,33S,36S,37S,38R,41S,43S,49S)-3,37-Diacetoxy-11-[7-chloro-4(S)-hydroxy-2-methylene-5(E),7-octadienyl]-10,14,15,17,27,43-hexahydroxy-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-8,12,45, |
149715-96-8 |
C63H95ClO21 |
|
N-[4-Oxo-4-(4-pyridinylamino)butyl]carbamic acid tert-butyl ester |
266353-29-1 |
C14H21N3O3 |
|
2-Chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepine |
014028-44-5 |
C17H16ClN3O |